Clinical impact of vancomycin-resistant enterococci

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue SUPPL. 3, 2003, Pages

  Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

Enterococci; Glycopeptide resistance; Vancomycin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTINEOPLASTIC AGENT; AVOPARCIN; AZTREONAM; CEFALEXIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; ORITAVANCIN; PIPERACILLIN PLUS TAZOBACTAM; RAMOPLANIN; SULTAMICILLIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTHRALGIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BLADDER CATHETERIZATION; CANCER PATIENT; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG USE; DRUG WITHDRAWAL; ENTEROCOCCUS; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; GASTROINTESTINAL INFECTION; HEMATOLOGY; HEMODIALYSIS; HOSPITAL HYGIENE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; INTESTINE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MUCOSA INFLAMMATION; MYALGIA; NEUTROPENIA; PATIENT CARE; RECIPIENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; SYMPTOM; THROMBOCYTOPENIA; TIME; TOTAL PARENTERAL NUTRITION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DEPSIPEPTIDES; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; PEPTIDES, CYCLIC; VANCOMYCIN RESISTANCE;

EID: 0038601540     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Patel, R. (1999). Vancomycin-resistant enterococci in solid organ transplantation. Current Opinion in Organ Transplantation 4, 271-80.
2. Patel, R. (2000). Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms. FEMS Microbiology Letters 185, 1-7.
3. Willems, R. J., Homan, W., Top, J., van Santen-Verheuvel, M., Tribe, D., Manzioros, X. et al. (2001). Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357, 853-5.
4. D'Agata, E. M. C., Jirjis, J., Gouldin, C. & Tang, Y. W. (2001). Community dissemination of vancomycin-resistant Enterococcus faecium. American Journal of Infection Control 29, 316-20.
5. Reid, K. C., Cockerill, F. R. & Patel, R. (2001). Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: A report of 20 cases. Clinical Infectious Diseases 32, 1540-6.
6. Patel, R., Uhl, J. R., Kohner, P., Hopkins, M. K. & Cockerill, F. R. (1997). Multiplex PCR detection of vanA, vanB, vanC1 and vanC2/3 genes in enterococci. Journal of Clinical Microbiology 35, 703-7.
7. Centers for Disease Control and Prevention. (1999). National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999. American Journal of Infection Control 27, 520-32.
8. Patel, R., Allen, S. L., Manahan, J. M., Wright, A. J., Krom, R. A. F., Wiesner, R. H. et al. (2001). Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transplantation 7, 27-31.
9. Siddiqui, A. H., Harris, A. D., Hebden, J., Wilson, P. D., Morris, J. G. & Roghmann, M. C. (2002). The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. American Journal of Infection Control 30, 40-3.
10. Baden, L. R., Thiemke, W., Skolnik, A., Chambers, R., Strymish, J., Gold, H. S. et al. (2001). Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of 'clearance'. Clinical Infectious Diseases 33, 1654-60.
11. Sandoe, J. A. T., Hall, J. M., Collyns, T. A., Witherden, I. R., Parnell, P., Woodrow, G. et al. (2002). An outbreak of vancomycin-resistant enterococci associated with major ward refurbishment. Journal of Hospital Infection 50, 79-80.
12. Bonten, M. J., Slaughter, S., Ambergen, A. W., Hayden, M. K., van Voorhis, J., Nathan, C. et al. (1998). The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: an important infection control variable. Archives of Internal Medicine 158, 1127-32.
13. Baran, J., Ramanathan, J., Riederer, K. M. & Khatib, R. (2002). Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infection Control and Hospital Epidemiology 23, 23-6.
14. Beltrami, E. M., Singer, D. A., Fish, L., Manning, K., Young, S., Banerjee, S. N. et al. (2000). Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. American Journal of Infection Control 28, 282-5.
15. Ostrowsky, B. E., Venkataraman, L., D'Agata, E. M., Gold, H. S., DeGirolami, P. C. & Samore, M. H. (1999). Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Archives of Internal Medicine 159, 1467-72.
16. Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M. et al. (2000). Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. New England Journal of Medicine 343, 1925-32.
17. Boyce, J. M., Opal, S. M., Chow, J. W., Zervos, M. J., Potter-Bynoe, G., Sherman, C. B. et al. (1994). Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. Journal of Clinical Microbiology 32, 1148-53.
18. Elizaga, M. L., Weinstein, R. A. & Hayden, M. K. (2002). Patients in long-term care facilities: A reservoir for vancomycin-resistant enterococci. Clinical Infectious Diseases 34, 441-6.
19. Tokars, J. I., Gehr, T., Jarvis, W. R., Anderson, J., Armistead, N., Miller, E. R. et al. (2001). Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers. Kidney International 60, 1511-6.
20. Donskey, C. J., Hanrahan, J. A., Hutton, R. A. & Rice, L. B. (2000). Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Journal of Infectious Diseases 181, 1830-3.
21. MacIntyre, C. R., Empson, M., Boardman, C., Sindhusake, D., Lokan, J. & Brown, G. V. (2001). Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infection Control and Hospital Epidemiology 22, 624-9.
22. Suntharam, N., Lankford, M. G., Trick, W. E., Peterson, L. R. & Noskin, G. A. (2002). Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagnostic Microbiology and Infectious Disease 43, 183-8.
23. D'Agata, E. M., Green, W. K., Schulman, G., Li, H., Tang, Y. W. & Schaffner, W. (2001). Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition. Clinical Infectious Diseases 32, 23-9.
24. Bradley, S. J., Wilson, A. L. T., Allen, M. C., Sher, H. A., Goldstone, A. H. & Scott, G. M. (1999). The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. Journal of Antimicrobial Chemotherapy 43, 261-6.
25. Quale, J., Landman, D., Saurina, G., Atwood, E., DiTore, V. & Patel, K. (1996). Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clinical Infectious Diseases 23, 1020-5.
26. Montecalvo, M. A., de Lencastre, H., Carraher, M., Gedris, C., Chung, M., VanHorn, K. et al. (1995). Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infection Control and Hospital Epidemiology 16, 680-5.
27. Roghmann, M. C., Qaiyumi, S., Schwalbe, R. & Morris, J. G., Jr (1997). Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infection Control and Hospital Epidemiology 18, 679-80.
28. Henning, K. J., Delencastre, H., Eagan, J., Boone, N., Brown, A., Chung, M. et al. (1996). Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatric Infectious Disease Journal 15, 848-54.
29. Donskey, C. J., Hoyen, C. K., Das, S. M., Helfand, M. S. & Hecker, M. T. (2002). Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infection Control and Hospital Epidemiology 23, 436-40.
30. Noskin, G. A., Bednarz, P., Suriano, T., Reiner, S. & Peterson, L. R. (2000). Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: Implications for upholstery selection in hospitals. American Journal of Infection Control 28, 311-3.
31. Montecalvo, M. A., Jarvis, W. R., Uman, J., Shay, D. K., Petrullo, C., Horowitz, H. W. et al. (2001). Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting. Infection Control and Hospital Epidemiology 22, 437-42.
32. D'Agata, E. M. C., Horn, M. A. & Webb, G. F. (2002). The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. Journal of Infectious Diseases 185, 766-73.
33. Larson, E. L., Early, E., Cloonan, P., Sugrue, S. & Parides, M. (2000). An organizational climate intervention associated with increased handwashing and decreased nosocomial infections. Behavioral Medicine 26, 14-22.
34. Ridwan, B., Mascini, E., van der Reijden, N., Verhoef, J. & Bonten, M. (2002). What action should be taken to prevent spread of vancomycin-resistant enterococci in European hospitals? British Medical Journal 324, 666-8.
35. Balzereit-Scheuerlein, F. & Stephan, R. (2001). Prevalence of colonisation and resistance patterns of vancomycin-resistant enterococci in healthy, non-hospitalised persons in Switzerland. Swiss Medical Weekly 131, 280-2.
36. Johnston, P. B., Litzow, M. R., Elliott, M. A., Ansell, S. M., Dispenzieri, A., Gastineau, D. A. et al. (2000). Colonization with vancomycin-resistant enterococcus correlates with poor outcome in patients undergoing allogeneic blood and marrow transplants. Blood 96, 786a.
37. Hachem, R. & Raad, I. (2002). Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infection Control and Hospital Epidemiology 23, 43-4.
38. Wong, A. H., Wenzel, R. P. & Edmond, M. B. (2000). Epidemiology of bacteriuria caused by vancomycin-resistant enterococci - a retrospective study. American Journal of Infection Control 28, 277-81.
39. Koc, Y., Snydman, D. R., Schenkein, D. S. & Miller, K. B. (1998). Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplantation 22, 207-9.
40. Bhavnani, S. M., Drake, J. A., Forrest, A., Deinhart, J. A., Jones, R. N., Biedenbach, D. J. et al. (2000). A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and-susceptible enterococcal bacteremia. Diagnostic Microbiology and Infectious Disease 36, 145-58.
41. Goetz, A. M., Rihs, J. D., Wagener, M. M. & Muder, R. R. (1998). Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. American Journal of Infection Control 26, 558-62.
42. Kuehnert, M. J., Jernigan, J. A., Pullen, A. L., Rimland, D. & Jarvis, W. R. (1999). Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infection Control and Hospital Epidemiology 20, 660-3.
43. Lautenbach, E., Bilker, W. B. & Brennan, P. J. (1999). Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality. Infection Control and Hospital Epidemiology 20, 318-23.
44. Peset, V., Tallon, P., Sola, C., Sanchez, E., Sarrion, A., Perez-Belles, C. et al. (2000). Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. European Journal of Clinical Microbiology and Infectious Diseases 19, 742-9.
45. Vergis, E. N., Hayden, M. K., Chow, J. W., Snydman, D. R., Zervos, M. J., Linden, P. K. et al. (2001). Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study. Annals of Internal Medicine 135, 484-92.
46. Husni, R., Hachem, R., Hanna, H. & Raad, I. (2002). Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infection Control and Hospital Epidemiology 23, 102-3.
47. Scagnelli, M., Pellizer, G., de Lalla, F., D'Emilio, A., Rassu, M., Bragagnolo, L. et al. (2001). Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in northern Italy. European Journal of Clinical Microbiology and Infectious Diseases 20, 609-16.
48. Donskey, C. J., Hanrahan, J. A., Hutton, R. A. & Rice, L. B. (1999). Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Journal of Infectious Diseases 180, 384-90.
49. Lodise, T. P., McKinnon, P. S., Tam, V. H. & Rybak, M. J. (2002). Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clinical Infectious Diseases 34, 922-9.
50. Stosor, V., Peterson, L. R., Postelnick, M. & Noskin, G. A. (1998). Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Archives of Internal Medicine 158, 522-7.
51. Garbutt, J. M., Ventrapragada, M., Littenberg, B. & Mundy, L. M. (2000). Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clinical Infectious Diseases 30, 466-72.
52. Jones, R. N., Ballow, C. H., Biedenbach, D. J., Deinhart, J. A. & Schentag, J. J. (1998). Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagnostic Microbiology and Infectious Disease 31, 437-51.
53. Luh, K., Hsueh, P., Teng, L., Pan, H., Chen, Y., Lu, J. et al. (2000). Quinupristin-dalfopristin resistance among Gram-positive bacteria in Taiwan. Antimicrobial Agents and Chemotherapy 44, 3374-80.
54. Patel, R., Rouse, M. S., Piper, K. E. & Steckelberg, J. M. (1999). In vitro activity of linezolid against va ncomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 34, 119-22.
55. Swaney, S. M., Aoki, H., Ganoza, M. C. & Shinabarger, D. L. (1998). The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrobial Agents and Chemotherapy 42, 3251-5.
56. Prystowsky, J., Siddiqui, F, Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R. et al. (2001). Resistance to linezolid: Characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy 45, 2154-6.
57. Herrero, I. A., Issa, N. C. & Patel, R. (2002). Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. New England Journal of Medicine 346, 867-9.
58. Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K. & Quinn, J. P. (2001). Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179.
59. Patel, R., Rouse, M. S., Piper, K. E., Cockerill, F. R. & Steckelberg, J. M. (1998). In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 30, 89-92.
60. Patel, R., Rouse, M. S., Piper, K. E. & Steckelberg, J. M. (2000). In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 38, 177-9.